Author Archive: Jeremy Parkinson

China Looking At Taking Stake In Aramco

China Looking At Taking Stake In Aramco

According to local sources in the Middle East, financial difficulties in Saudi Arabia may see a cash injection coming for its oil industry – Aramco. The Saudis are considering a private placement of its shares instead of a traditional float of shares on the stock exchange. The buyer is of course China. Saudi Aramco has been considering the international […]
Chart Of The Day: Mind The Machines

Chart Of The Day: Mind The Machines

 
Approaching Effective Demand Limit Again

Approaching Effective Demand Limit Again

The famous economist John Maynard Keynes tried to put forth a theory of effective demand. Keynes even devoted chapter 3 of his General Theory book to it. However, nowadays you will not see the term effective demand in economic textbooks. What happened to it? Why is the term effective demand missing from common discourse? Keynes […]
Aurora Cannabis Inc. Vs. Aphria Inc.: Which One Is A Better Buy?

Aurora Cannabis Inc. Vs. Aphria Inc.: Which One Is A Better Buy?

Written by SmallCapPower.com For more than a year now, the cannabis industry has been the hot topic for investors given the impending Canada marijuana legalization legislation in July 2018. Consequently, the current valuations for many of the cannabis stocks are high and the companies have much to prove. As most marijuana stock investors know, the […]
Netflix, Inc. Q3 2017 Earnings Preview: Stock Hits $200 For The First Time

Netflix, Inc. Q3 2017 Earnings Preview: Stock Hits $200 For The First Time

Netflix Q3 2017 earnings are slated for release on Monday after closing bell. Consensus stands at 32 cents per share in earnings on $2.97 billion in revenue. In last year’s third quarter, the streaming video provider reported earnings of 12 cents per share on $2.29 billion in revenue. jgryntysz/Pixabay Netflix recently announced that it’s raising monthly […]
E
                                                
                        What To Expect From Apple’s Earnings Report

E What To Expect From Apple’s Earnings Report

Apple (AAPL) shares fell 8.7% from the all-time high of $164.94 on September 1, to $150.55 on September 25, due to some disappointment among customers that the much-awaited iPhone X will start shipping only at the beginning of November. Since then Apple shares have regained 4.3% to $156.99 on October 13. As I see it, […]
How To Prepare For The Return Of Market Volatility

How To Prepare For The Return Of Market Volatility

Markets remained calm as corporate earnings satisfied investors and controversial actions from the White House surrounding Obamacare and Iran were largely ignored by investors. The situation around the Catalonia region declaring independence remains fierce but some indications of willingness to work with the central government helped the Euro. Weekly Returns: S&P 500: 2,553 (+0.2%) FTSE […]
USDCHF: Risk Builds Up On The Upside

USDCHF: Risk Builds Up On The Upside

USDCHF: With the pair closing marginally lower on  rejection candle on Friday, it now looks to recover further higher. On the downside, support lies at the 0.9700 level. A turn below here will open the door for more weakness towards the 0.9650 level and then the 0.9600 level. On the upside, resistance resides at the […]
Pay-TV Companies Tank As Subscriber Losses Surge To Record Highs In 2017

Pay-TV Companies Tank As Subscriber Losses Surge To Record Highs In 2017

As the broader markets casually melt-up to new record highs with each passing day, one small corner of the equity market is in full on meltdown mode: cable and satellite pay-tv providers. Down anywhere from 3-10% on the week, investors in this space seem to be finally admitting that record subscriber losses, quarter after quarter, […]
How To Get Involved In The Drug Trade (It’s Not What You Think)

How To Get Involved In The Drug Trade (It’s Not What You Think)

Eli Lilly & Co. (LLY), one of the world’s largest drug manufacturers, has seen its stock go nowhere for 2 years. We don’t know many participants who would like a 0% return for 24 months. But this nowhere action is perfectly normal behavior. After all, Eli Lilly was up over 350% from the bottom in 2009 through September 2015. That’s […]